Literature DB >> 1562660

Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations.

D Lucey1, M J Dolan, C W Moss, M Garcia, D G Hollis, S Wegner, G Morgan, R Almeida, D Leong, K S Greisen.   

Abstract

Two previously healthy, immunocompetent men had persistent Rochalimaea henselae bacteremia with clinical relapses after courses of antibiotics to which the isolates were ultimately demonstrated susceptible in vitro. Both had sustained tick bites prior to their illnesses, thus demonstrating an association not previously identified, although suspected. The first patient had relapsing fever, constitutional symptoms, and an episode of aseptic meningitis despite therapy with amoxicillin, then with doxycycline, and then with ceftriaxone. Thereafter, he spontaneously became asymptomatic during a span of 2 months of persistent bacteremia. Finally, after 2 weeks of therapy with ceftriaxone plus gentamicin, followed by 4 weeks of therapy with oral ciprofloxacin, his bacteremia was cured. The second man had relapsing fever and constitutional symptoms after courses of tetracycline, then of chloramphenicol, and then of doxycycline. He became permanently asymptomatic after serial 2-week courses of chloramphenicol and erythromycin. The greater efficacy of lysis-centrifugation blood cultures in the recovery of R. henselae was noted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562660     DOI: 10.1093/clinids/14.3.683

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  64 in total

1.  Bartonella henselae infection as a cause of fever of unknown origin.

Authors:  M Tsukahara; H Tsuneoka; H Iino; I Murano; H Takahashi; M Uchida
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 2.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 3.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

Review 4.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

5.  Cryptogenic hepatitis and bartonellosis.

Authors:  Paulo Eduardo Neves Ferreira Velho; Marna Elise Ericson
Journal:  Dig Dis Sci       Date:  2012-02-04       Impact factor: 3.199

6.  Conservation of the 17-kilodalton antigen gene within the genus Bartonella.

Authors:  D Sweger; S Resto-Ruiz; D P Johnson; M Schmiederer; N Hawke; B Anderson
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

7.  Infection and replication of Bartonella species within a tick cell line.

Authors:  Sarah A Billeter; Pedro Paulo V P Diniz; James M Battisti; Ulrike G Munderloh; Edward B Breitschwerdt; Michael G Levy
Journal:  Exp Appl Acarol       Date:  2009-02-26       Impact factor: 2.132

8.  Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells.

Authors:  H J Batterman; J A Peek; J S Loutit; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Genomic fingerprinting of Bartonella species by repetitive element PCR for distinguishing species and isolates.

Authors:  M C Rodriguez-Barradas; R J Hamill; E D Houston; P R Georghiou; J E Clarridge; R L Regnery; J E Koehler
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping.

Authors:  G M Matar; B Swaminathan; S B Hunter; L N Slater; D F Welch
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.